• Aucun résultat trouvé

Normal and Pathological Placental Angiogenesis

N/A
N/A
Protected

Academic year: 2021

Partager "Normal and Pathological Placental Angiogenesis"

Copied!
4
0
0

Texte intégral

(1)

HAL Id: hal-01234615

https://hal-amu.archives-ouvertes.fr/hal-01234615

Submitted on 27 Nov 2015

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Normal and Pathological Placental Angiogenesis

Nathalie Bardin, Padma Murthi, Nadia Alfaidy

To cite this version:

Nathalie Bardin, Padma Murthi, Nadia Alfaidy. Normal and Pathological Placental Angiogenesis.

BioMed Research International , Hindawi Publishing Corporation, 2015, �10.1155/2015/354359�.

�hal-01234615�

(2)

Editorial

Normal and Pathological Placental Angiogenesis

Nathalie Bardin,

1

Padma Murthi,

2

and Nadia Alfaidy

3

1Inserm UMR-S 1076, Facult´e de Pharmacie, Aix-Marseille University, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France

2Department of Obstetrics and Gynaecology (RWH), University of Melbourne, Parkville, VIC 3052, Australia

3Inserm U1036, University Grenoble Alpes, CEA, 38054 Grenoble, France

Correspondence should be addressed to Nadia Alfaidy; nadia.alfaidy-benharouga@cea.fr Received 6 November 2014; Accepted 6 November 2014

Copyright © 2015 Nathalie Bardin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Placental angiogenesis is a pivotal process that estab-lishes fetomaternal circulation, ensures efficient maternofetal exchanges, plays a key mechanistic role in the elaboration of the placental villous tree, and contributes to the overall development of the placenta throughout pregnancy. Failure in these processes is tightly linked to the development of placental pathologies such as preeclampsia (PE), early pregnancy loss, and intrauterine growth restriction (IUGR). It is now well established that a close relationship exists between embryonic development and the degree of placental angiogenesis. A key discovery in the investigation of placental pathologies was the understanding that major phenotypes of PE are associated with dysregulation in angiogenic factors. During the last decade multiple new key angiogenic pro-teins have been reported to play crucial roles in placental angiogenesis; these include netrins, EG-VEGF (endocrine gland derived endothelial growth factor), and angiogenin. Furthermore, placental angiogenesis appears to also be reg-ulated by specific microRNAs (miRNAs), deregulations of which have also been shown to be associated with pregnancy pathologies. By affecting placental angiogenesis, numerous insults have been shown to influence pregnancy outcomes. These include (i) oxidative stress, (ii) hyperglycemia, and (iii) failure in immune system adaptations to pregnancy, such as the presence of antiphospholipid antibodies (aPL) and/or soluble Mic (sMIC).

In the present scope authors reported new findings in the field of placental angiogenesis, discussed the advancements made in the diagnosis of pathologies reported to be associated with placental angiogenesis, and brought new insights into the processes of vasculogenesis and angiogenesis occurring

throughout pregnancy in the placenta. More importantly, regulators of the key protagonists of vascular and angiogenic processes have been reported and their roles discussed.

The reviews by M. Dakouane-Giudicelli et al., N. Pavlov et al., and N. Alfaidy et al. reported the role of three newly discovered angiogenic placental factors, 1 and netrin-4, angiogenin, and EG-VEGF, respectively. M. Dakouane-Giudicelli et al. highlighted the opposite role that netrin-1 and netrin-4 might play in normal and pathological pregnancies. Netrin-1 and netrin-4 have been found to be either proangio-genic or antiangioproangio-genic factors in the human placenta. These opposite effects appear to be related to the endothelial cell phenotype studied and seem also to depend on the type of receptor to which each netrin binds.

N. Pavlov et al. demonstrated that the proangiogenic protein, angiogenin, might play a key role in placental blood vessel formation as well as in the cross talk between trophoblasts and endothelial cells. The review by N. Alfaidy et al. recapitulates EG-VEGF mediated-angiogenesis within the placenta and at the fetomaternal interface and proposes that its deregulation might contribute to the pathogenesis of several placental pathologies including IUGR and PE. More importantly, this article argues for EG-VEGF clinical relevance as a potential biomarker of the onset of pregnancy pathologies and discusses its potential usefulness for future therapeutic directions.

In a second set of reviews of the scope Dr. R. D. Pereira et al. reported the effect of oxidative stress on the expression of a number of transcription factors that are important in mediating angiogenesis and stressed that the understanding of how oxidative stress affects redox-sensitive transcription Hindawi Publishing Corporation

BioMed Research International Volume 2015, Article ID 354359, 2 pages http://dx.doi.org/10.1155/2015/354359

(3)

2 BioMed Research International factors within the placenta may elucidate potential

therapeu-tic targets to correct abnormal placental angiogenesis and function. In the same context, S. Cvitic et al. described the major regulators of placental angiogenesis and demonstrated how the diabetic environment in utero alters their expression. In relation to immune placental pathologies that affect placental vascularization and angiogenesis, J. B. Haumonte et al. work suggests that detection of sMIC molecules in maternal plasma may constitute a hallmark of altered mater-nal immune functions associated with vascular disorders that contributes to poor pregnancy outcomes, notably by impairing NK-cell mediated production of IFN gamma, an essential cytokine favoring vascular modeling. In the same perspective, O. Paulmyer-Lacroix et al. highlighted the menace of antiphospholipid antibodies (aPL) positive patients on placental vascular development during implan-tation. These findings propose aPL assessment, in particular a𝛽2GPI IgA antibodies, as a novel therapeutic strategy to improve pregnancy outcome.

Finally, M. Tsochandaridis et al. highlighted a major topic of interest for clinicians and biologists that concern maternal and fetal monitoring and their importance in predicting pregnancy complications. Her work has addressed the poten-tial role of circulating as well as placental miRNAs that are associated with abnormal angiogenesis.

Overall the present scope on this special issue summa-rizes key aspects of placental angiogenesis during normal and pathological pregnancies. The scope will expand our knowledge in this field and allow better understanding of the associated mechanisms to placental angiogenesis.

Nathalie Bardin Padma Murthi Nadia Alfaidy

(4)

Submit your manuscripts at

http://www.hindawi.com

Pain

Research and Treatment

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

The Scientific

World Journal

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Toxins

Journal of

Vaccines

Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Antibiotics

International Journal of

Toxicology

Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Stroke

Research and Treatment

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Drug Delivery

Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014 Advances in Pharmacological Sciences

Tropical Medicine

Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Medicinal ChemistryInternational Journal of Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Addiction

Journal of Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

BioMed

Research International Emergency Medicine International

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Autoimmune

Diseases

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Anesthesiology Research and Practice

Scientifica

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Pharmaceutics

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

MEDIATORS

Références

Documents relatifs

Effects of maternal Au-NP exposure by ingestion on feto-placental develop- ment and placental function, in a rabbit model. International Conference on Health and Safety issues

The aim was to evaluate the effects of maternal sub- chronic Au-NP inhalation throughout the gestation on the foeto-placental development and placental function in a rabbit model..

Here, we compare the results of this Matsubara voltage quantum Monte Carlo (MV-QMC) approach to data obtained with a scattering states numerical renormalization group (SNRG)

Evaluation of the anti-angiogenic effects of the test compounds took place by image processing and analysis workflow described next, that measured various

Fetal gonads Utero-placental unit Utero-placental unit Mare Mare P5 17αOH Pregnenolone Dehydroepiandrost erone (DHEA) 7-dehydro DHEA Androstendio ne Testoster one Oestrone

Après validation du modèle MEF, une autre comparaison avec le calcul analytique du tronçon selon l'EC3 [24].Les résultats obtenus sont illustrés dans la figure 69 et les tables

We identified some SNPs in clock- related genes (e.g., rs2899663 in the RORA gene) in the placental genome that are associ- ated with placental abruption risk, and these

Findings from recent PA-related genome-wide association studies (GWAS) and candidate gene association studies (mitochondrial biogenesis and oxidative phosphorylation pathway genes)